# Famotidine H2 Blocker Dose: Gastric Acid Reduction Guide Dogs Cats ## Key Takeaways - Famotidine is an H2 receptor antagonist used to reduce gastric acid production in dogs and cats, with standard oral doses of 0.5-1.1 mg/kg every 12 hours for dogs and 0.5-1.0 mg/kg every 12-24 hours for cats. - Intragastric pH monitoring studies in dogs suggest continuous rate infusion (CRI) of famotidine may provide more consistent acid suppression (pH > 3 for >90% of the time) compared to intermittent IV dosing (pH > 3 for 42-49% of the time). - Famotidine is indicated for gastric/duodenal ulceration, GERD, prevention of stress ulcers in critically ill patients, and in conjunction with antihistamines for mast cell tumors. - Famotidine can affect the absorption of other medications by raising gastric pH; administration should be separated by at least 2 hours from other oral drugs. - While human studies suggest oral proton pump inhibitors (PPIs) provide more consistent acid suppression than oral famotidine, famotidine CRI can be as effective as PPIs in dogs and offers a cost-effective alternative. - Dosing in cats is often extrapolated from canine data, and caution is advised due to different drug metabolism; cats with chronic kidney disease may require dose adjustments. --- Famotidine is a histamine-2 (H2) receptor antagonist commonly used in veterinary medicine to reduce gastric acid production in dogs and cats. The standard oral dose for dogs is 0.5 to 1.1 mg per kilogram (mg/kg) every 12 hours. For cats, the typical dose is 0.5 to 1.0 mg/kg every 12 to 24 hours. This guide explains the evidence behind famotidine dosing, how it compares to other acid suppressants, and what pet owners should discuss with their veterinarian. **Owner Triage Summary:** If your [dog](/knowledge/veterinary-medicine/clinical-methods/dog) or [cat](/knowledge/veterinary-medicine/clinical-methods/cat) is vomiting blood, has black tarry stools, shows severe abdominal pain, or collapses, seek emergency veterinary care immediately. Do not attempt to treat these signs at home. For mild gastrointestinal upset, such as occasional vomiting or reduced appetite, contact your veterinarian before administering any medication. Famotidine is a prescription medication in many regions and should only be used under veterinary guidance. ## At a Glance: Famotidine Dosing and Efficacy | Parameter | Dogs | Cats | |------|---|---| | **Oral Dose** | 0.5 to 1.1 mg/kg every 12 hours | 0.5 to 1.0 mg/kg every 12 to 24 hours | | **IV Intermittent Dose** | 0.5 to 1.0 mg/kg every 12 hours | 0.5 to 1.0 mg/kg every 12 hours | | **IV Continuous Rate Infusion (CRI)** | 1.0 mg/kg loading dose, then 8.0 mg/kg/day | Not well established in published trials | | **Time to Peak Effect (Oral)** | 1 to 2 hours | 1 to 2 hours | | **Duration of Action** | 8 to 12 hours | 8 to 12 hours | | **Primary Use** | Gastric ulceration, esophagitis, reflux, prevention of stress ulcers | Similar to dogs | | **Common Side Effects** | Diarrhea, vomiting, reduced appetite | Diarrhea, vomiting, reduced appetite | **Key Efficacy Note:** In a 2019 study of healthy Beagles, famotidine administered as a continuous rate infusion (CRI) maintained intragastric pH at or above 3 for over 90% of the monitoring period on days 1, 2, and 3. The same study found that intermittent IV dosing every 12 hours maintained pH at or above 3 for only 42 to 49% of the time [1]. This suggests that CRI may be superior for critically ill dogs requiring consistent acid suppression. ## Understanding Gastric Acid and the Role of H2 Blockers The stomach produces hydrochloric acid to aid digestion and kill ingested pathogens. Acid production is stimulated by three main pathways: histamine, gastrin, and acetylcholine. Histamine binds to H2 receptors on parietal cells in the gastric mucosa, triggering acid secretion. Famotidine works by competitively blocking these H2 receptors, reducing both basal and stimulated acid production. Famotidine belongs to the H2 receptor antagonist class, which also includes cimetidine, ranitidine, and nizatidine. Among these, famotidine is often preferred in veterinary medicine because it is more potent on a milligram basis and has fewer drug interactions than cimetidine. It is also less likely to cause the central nervous system side effects occasionally seen with older H2 blockers. The goal of acid suppression therapy is to raise intragastric pH above 3 or 4. A pH above 3 allows platelets to aggregate and stabilize clots in bleeding ulcers, while a pH above 4 reduces pepsin activity and prevents further mucosal damage. These thresholds are used in both human and veterinary studies to assess treatment efficacy [2][1]. ## When Is Famotidine Used in Dogs and Cats? Famotidine is prescribed for several conditions in small animal practice: **Gastric and duodenal ulceration:** Ulcers can develop from stress, neoplasia, or medications such as nonsteroidal anti-inflammatory drugs (NSAIDs). Acid suppression allows existing ulcers to heal and prevents new ones from forming. In a rat model of indomethacin-induced gastric ulcers, famotidine demonstrated significant ulcer inhibition, confirming its gastroprotective effects [3]. **Gastroesophageal reflux disease (GERD):** Reflux of stomach acid into the esophagus causes inflammation and pain. Reducing acid production decreases esophageal irritation. This is particularly relevant for brachycephalic breeds predisposed to reflux. **Prevention of stress ulcers in critically ill patients:** Hospitalized dogs with severe systemic illness are at risk for gastrointestinal bleeding. The 2020 study by Kuhl and colleagues evaluated IV acid suppressants in healthy dogs and noted that upper GI ulceration and bleeding in critically ill dogs can cause severe anemia and increase morbidity [2]. Acid suppression is therefore part of standard critical care protocols. **Mast cell tumors:** Mast cells release histamine, which stimulates acid secretion. Famotidine is often used alongside antihistamines in dogs with mast cell tumors to reduce histamine-driven gastric acid production. **Esophagitis:** Inflammation of the esophagus from chronic vomiting or foreign body trauma benefits from reduced acid exposure. ## Evidence for Famotidine Efficacy in Dogs The most relevant veterinary studies on famotidine come from a group of researchers at the University of Tennessee. Their work has focused on intragastric pH monitoring in healthy Beagles. The 2019 study by Hedges and colleagues compared two famotidine protocols. In a randomized 2-way crossover design, nine healthy Beagles received either famotidine at 1.0 mg/kg IV every 12 hours or a CRI protocol consisting of a 1.0 mg/kg IV loading dose followed by 8.0 mg/kg/day. Continuous intragastric pH monitoring was performed for three consecutive days. Results showed a statistically significant difference between the two protocols. The CRI group maintained pH at or above 3 for 92.1%, 96.3%, and 90.0% of the time on days 1, 2, and 3 respectively. The intermittent group achieved pH at or above 3 for only 49.3%, 42.2%, and 45.8% of the time on the same days [1]. This study is clinically important because it demonstrates that standard intermittent famotidine dosing may not provide consistent acid suppression in dogs. The authors noted that CRI treatment with famotidine met clinical goals for raising intragastric pH to 3 or above, while intermittent dosing did not reliably achieve this target [1]. The 2020 study by Kuhl and colleagues expanded on this work by comparing famotidine CRI to two proton pump inhibitors (PPIs): pantoprazole and esomeprazole. All three treatments significantly increased mean intragastric pH and the percentage of time pH was at or above 3 and 4. However, the time effect did not differ by treatment, meaning all three drugs were similarly effective when famotidine was given as a CRI [2]. These findings suggest that famotidine, when administered appropriately, can be as effective as PPIs for raising gastric pH in dogs. The key is the route and frequency of administration. Intermittent dosing every 12 hours may not be sufficient for critically ill patients. ## Evidence for Famotidine Efficacy in Cats Published veterinary studies specifically evaluating famotidine in cats are limited. Most dosing recommendations are extrapolated from canine studies or human data. The Merck Veterinary Manual and standard veterinary pharmacology texts recommend famotidine at 0.5 to 1.0 mg/kg every 12 to 24 hours for cats. Cats metabolize drugs differently than dogs, and they are more prone to adverse drug reactions. Caution is advised when using any acid suppressant in cats long-term. The feline dose is often given once daily to reduce the risk of side effects. One important consideration is that cats with chronic kidney disease (CKD) often have increased gastric acid production due to uremia. Famotidine may be used to manage uremic gastritis, but dosing adjustments may be needed in cats with reduced renal function. Discuss this with your veterinarian if your cat has CKD. ## Comparison with Proton Pump Inhibitors Proton pump inhibitors (PPIs) such as omeprazole, pantoprazole, and esomeprazole are the other major class of acid suppressants. PPIs irreversibly inhibit the proton pump in parietal cells, providing more potent and longer-lasting acid suppression than H2 blockers. In human medicine, PPIs are generally considered superior to H2 blockers for healing erosive esophagitis and preventing NSAID-induced ulcers. A 2021 randomized controlled trial in high-risk users of low-dose aspirin found that omeprazole 20 mg once daily was more effective than famotidine 20 mg twice daily in preventing gastroduodenal mucosal breaks. The incidence of mucosal breaks was 19.8% in the omeprazole group versus 33.8% in the famotidine group [4]. However, this does not mean PPIs are always the better choice in veterinary patients. The 2020 canine study found that famotidine CRI was as effective as esomeprazole and pantoprazole [2]. For hospitalized dogs where IV access is available, famotidine CRI offers a cost-effective alternative to PPIs. For oral outpatient therapy, PPIs may provide more consistent acid suppression. A 2023 human study comparing low-dose esomeprazole (10 mg and 20 mg) to famotidine 20 mg found that esomeprazole maintained gastric pH above 4 for a greater percentage of time. After multiple doses, the mean percentages of time pH was above 4 were 35.77% for esomeprazole 10 mg, 53.75% for esomeprazole 20 mg, and 24.48% for famotidine 20 mg [5]. A 2024 study using a dual delayed-release formulation of esomeprazole 10 mg found it maintained pH above 4 for 47.31% of the time versus 23.88% for famotidine 20 mg [6]. These human data suggest that oral PPIs provide more reliable acid suppression than oral famotidine. For dogs and cats requiring oral acid suppression, veterinarians may prefer PPIs. However, famotidine has advantages including lower cost, faster onset of action, and fewer long-term side effects. ## Pharmacokinetics and Dosing Considerations Famotidine is well absorbed after oral administration, with peak plasma concentrations occurring 1 to 2 hours after dosing. Food can reduce the rate of absorption, so it is often recommended to give famotidine on an empty stomach. However, this is not always practical for pets, and the clinical significance is uncertain. The drug is eliminated primarily unchanged in the urine. In patients with renal impairment, the dosing interval may need to be extended. This is particularly relevant for older cats with CKD and dogs with kidney disease. Famotidine has a relatively short duration of action compared to PPIs. This is why twice-daily dosing is typically recommended for dogs. The CRI studies in dogs used a loading dose of 1.0 mg/kg followed by 8.0 mg/kg/day, which is equivalent to approximately 0.33 mg/kg/hour [1]. ## Drug Interactions and Precautions Famotidine can affect the absorption of other medications by raising gastric pH. Drugs that require an acidic environment for optimal absorption may be less effective when co-administered with famotidine. In human medicine, famotidine has been shown to reduce the absorption of weakly basic drugs. A 2024 study found that famotidine caused a 2.4-fold lower exposure of a weakly basic TYK2 inhibitor in rats, implying that pH-dependent oral absorption can reduce active drug exposure and translate to subtherapeutic treatment [7]. Similarly, famotidine decreased the Cmax of daridorexant, a dual orexin receptor antagonist, by 39% in healthy subjects [8]. In contrast, famotidine increased the exposure of cilofexor by 3.2-fold for AUC and 6.1-fold for Cmax in healthy participants [9]. These examples illustrate that acid-reducing agents can have unpredictable effects on drug absorption. For veterinary patients, this means that famotidine should be given at a different time than other oral medications. A common recommendation is to separate famotidine from other drugs by at least 2 hours. Discuss specific medication timing with your veterinarian. Famotidine may also affect carnitine levels. A 2025 study in tube-fed patients with severe motor and intellectual disabilities found that famotidine users required significantly higher L-carnitine doses to maintain normal free carnitine levels compared to non-users (22.0 mg/kg/day versus 13.0 mg/kg/day) [10]. While this study was in humans, it raises a theoretical concern for long-term famotidine use in animals, particularly those on restricted diets. ## Unsafe Home Remedies and Owner Misconceptions Pet owners sometimes attempt to treat gastrointestinal issues at home with human medications or home remedies. This can be dangerous. **Do not give famotidine without veterinary approval.** While famotidine is generally safe, the underlying condition may require more aggressive treatment. Vomiting can be a sign of toxin exposure, foreign body obstruction, pancreatitis, or organ failure. Delaying veterinary care while trying home treatment can worsen the outcome. **Do not use expired famotidine.** Expired medications may lose potency or degrade into harmful compounds. **Do not assume human famotidine is identical to veterinary formulations.** Human tablets often contain additional ingredients such as flavorings or coatings that may not be safe for pets. Always use veterinary-prescribed formulations. **Do not combine famotidine with other acid suppressants unless directed.** Combining an H2 blocker with a PPI is rarely necessary and may increase the risk of side effects. **Do not use famotidine to mask symptoms.** If your pet is vomiting or has diarrhea, famotidine will not address the underlying cause. It only reduces acid production. A pet that appears to improve on famotidine may still have a serious condition that requires treatment. ## Prevention and Long-Term Management Preventing gastric ulcers and acid-related disease involves addressing underlying risk factors: **NSAID use:** NSAIDs such as carprofen, meloxicam, and aspirin can cause gastric ulcers. In rats, indomethacin-induced ulcers were significantly inhibited by famotidine [3]. If your pet requires long-term NSAID therapy, your veterinarian may recommend a gastroprotectant. However, the 2020 study by Satoh and colleagues in mice found that H2 receptor antagonists including famotidine did not prevent NSAID-induced antral ulcers, while PPIs were effective [11]. This suggests that PPIs may be preferred for NSAID prophylaxis. **Diet:** Feeding a bland, easily digestible diet during gastrointestinal upset can reduce irritation. However, there is no evidence that any specific diet prevents ulcers in otherwise healthy pets. **Stress reduction:** Stress can increase gastric acid production. For hospitalized pets, minimizing stress and providing appropriate analgesia may reduce the risk of stress ulcers. **Regular veterinary checkups:** Early detection of conditions that predispose to ulcers, such as mast cell tumors or inflammatory bowel disease, allows for earlier intervention. ## Prognosis and Monitoring The prognosis for pets with acid-related disease depends on the underlying cause. For simple gastritis or esophagitis, the prognosis is excellent with appropriate treatment. For gastric ulcers caused by NSAIDs, most pets recover fully once the offending drug is discontinued and acid suppression is provided. For critically ill pets with gastrointestinal bleeding, the prognosis is more guarded. The 2020 study by Kuhl and colleagues noted that upper GI ulceration and bleeding in critically ill dogs can cause severe anemia and increase morbidity [2]. These patients require intensive monitoring, including serial hematocrit measurements, blood pressure monitoring, and possibly blood transfusions. Monitoring for pets on famotidine includes: - Observation for vomiting, diarrhea, or changes in appetite - Monitoring for signs of gastrointestinal bleeding (black tarry stools, pale gums) - Regular veterinary rechecks to assess response to therapy - Blood work to monitor renal function if long-term therapy is needed ## Limitations and When to Contact a Veterinarian This article provides general information about famotidine dosing and efficacy. It cannot predict how an individual pet will respond to treatment. Breed-level information is limited because most veterinary studies use healthy Beagles or other purpose-bred dogs [2][1]. Cats are underrepresented in the published literature. **Contact your veterinarian immediately if:** - Your pet vomits blood or has black, tarry stools - Your pet shows signs of severe abdominal pain (pacing, crying, reluctance to move) - Your pet collapses or appears weak - Your pet has not eaten for more than 24 hours - Your pet has persistent vomiting or diarrhea for more than 24 hours - Your pet is lethargic or depressed - Your pet has known kidney disease and you are considering famotidine **Do not adjust your pet's medication dose without veterinary guidance.** Overdosing famotidine can cause serious side effects, while underdosing may be ineffective. ## Clinical Reasoning Behind Dose Selection and Treatment Targets Understanding why veterinarians choose specific famotidine doses requires a closer look at the physiology of gastric acid secretion and the clinical goals of acid suppression. The parietal cells of the stomach are stimulated through three primary pathways: histamine, gastrin, and acetylcholine. Histamine, released from enterochromaffin-like cells in the gastric mucosa, is the final common pathway that activates the H2 receptor on the parietal cell. By competitively blocking this receptor, famotidine reduces both basal acid secretion and the acid response to food and other stimuli. This mechanism explains why famotidine is effective for conditions where acid is a primary driver of tissue injury, such as esophagitis and gastric ulceration. The clinical target for acid suppression in veterinary medicine is an intragastric pH of at least 3, and ideally 4 or higher. A pH above 3 is the threshold at which platelet aggregation and clot formation can occur, which is critical for stopping active bleeding from ulcers. A pH above 4 inactivates pepsin, the enzyme that can continue to damage the gastric mucosa even after the initial insult has been removed. These thresholds are not arbitrary; they are derived from human critical care literature and have been adopted in veterinary studies to standardize efficacy assessments [2][1]. When evaluating whether a famotidine protocol is working, your veterinarian is essentially asking whether the drug is keeping gastric pH above these protective thresholds for a meaningful portion of the day. The dose selection for an individual pet is not a one-size-fits-all calculation. While the standard oral dose for dogs is 0.5 to 1.1 mg/kg every 12 hours, the higher end of this range is often reserved for patients with confirmed ulcers or severe esophagitis, while the lower end may be used for prophylaxis in patients starting NSAID therapy. For cats, the dose range of 0.5 to 1.0 mg/kg every 12 to 24 hours reflects the uncertainty in the feline literature and the need to individualize therapy based on the patient's renal function and underlying condition. The dosing interval is particularly important because famotidine has a relatively short duration of action compared to proton pump inhibitors. In healthy dogs, the duration of acid suppression from a single oral dose is approximately 8 to 12 hours, which is why twice-daily dosing is standard for most canine patients. ## Diagnostic Workflow Before Starting Famotidine Before your veterinarian prescribes famotidine, they will typically perform a diagnostic workup to determine the underlying cause of your pet's gastrointestinal signs. This is not unnecessary testing; it is essential for selecting the correct treatment and avoiding the mistake of masking a serious condition with acid suppression. The diagnostic approach usually begins with a thorough history and physical examination. Your veterinarian will ask about the onset and frequency of vomiting, the appearance of the vomitus, whether there is diarrhea, changes in appetite, weight loss, and any recent exposure to medications, toxins, or dietary changes. A history of NSAID administration is particularly important, as this is one of the most common causes of gastric ulceration in dogs. The physical examination will include abdominal palpation to assess for pain, masses, or organomegaly, as well as evaluation of mucous membrane color and capillary refill time to check for signs of blood loss or dehydration. If the history and physical examination suggest a need for acid suppression, your veterinarian may recommend baseline blood work. A complete blood count can reveal anemia, which may indicate chronic blood loss from an ulcer. Serum biochemistry can assess kidney and liver function, both of which are relevant to famotidine dosing and metabolism. Kidney disease is a common indication for acid suppression in cats, but it also requires dose adjustment because famotidine is eliminated primarily through renal excretion. Liver disease can affect drug metabolism and may influence the choice of acid suppressant. In some cases, your veterinarian may recommend abdominal imaging, such as ultrasound, to evaluate the stomach and intestines for masses, thickening, or foreign bodies. Ultrasound is particularly useful for identifying gastric tumors, which can present with signs similar to simple gastritis. For pets with persistent vomiting, hematemesis, or suspected foreign body obstruction, more advanced diagnostics may be necessary. Upper gastrointestinal endoscopy allows direct visualization of the esophagus, stomach, and proximal duodenum. This is the gold standard for diagnosing gastric ulcers, erosions, and esophagitis. During endoscopy, your veterinarian can take biopsy samples to differentiate between inflammatory conditions, neoplasia, and infectious causes. Endoscopy is also therapeutic in some cases, as bleeding ulcers can be treated directly. However, endoscopy requires general anesthesia, which carries its own risks, particularly in critically ill patients. Your veterinarian will weigh the diagnostic benefit against the anesthetic risk and may choose to start empirical famotidine therapy while stabilizing the patient before pursuing more invasive testing. ## Evidence Limitations and Gaps in the Veterinary Literature It is important for pet owners to understand that the evidence base for famotidine in veterinary medicine has significant limitations. The most rigorous studies have been conducted in healthy purpose-bred Beagles, which may not reflect the response of sick patients or other breeds [2][1]. Healthy dogs have normal gastric physiology, intact renal function, and no concurrent disease. Critically ill dogs, on the other hand, often have altered drug metabolism, reduced renal perfusion, and multiple organ dysfunction, all of which can affect how famotidine is absorbed, distributed, and eliminated. The pharmacokinetics of famotidine in sick patients may differ substantially from healthy volunteers, meaning that the doses validated in research settings may not be directly transferable to the intensive care unit. The feline literature is even more limited. There are no large randomized controlled trials evaluating famotidine in cats with naturally occurring disease. Most feline dosing recommendations are extrapolated from canine studies or from human data, which is not ideal because cats have unique drug metabolism pathways. Cats are deficient in certain glucuronidation enzymes, which affects how they process many drugs. While famotidine is not primarily metabolized through glucuronidation, the lack of species-specific data means that veterinarians must rely on clinical experience and cautious dose selection. The once-daily dosing interval often used in cats is based more on convenience and safety concerns than on pharmacokinetic evidence demonstrating that twice-daily dosing is unnecessary. Another limitation is that most studies measure intragastric pH as a surrogate endpoint, not clinical outcomes such as ulcer healing rates, transfusion requirements, or survival. A drug that raises pH effectively may not necessarily improve patient outcomes if the underlying disease is not addressed. The 2020 study by Kuhl and colleagues compared famotidine CRI to PPIs in healthy dogs and found similar pH effects, but this does not tell us whether famotidine is equally effective at preventing clinically significant bleeding in critically ill patients [2]. Clinical trials in sick animals are difficult to conduct due to ethical constraints, cost, and the heterogeneity of the patient population. As a result, much of the clinical decision-making in veterinary gastroenterology is based on extrapolation from human medicine and small animal studies. ## Owner Observation and Preparation for a Veterinary Visit Pet owners play a critical role in the successful management of acid-related disease. The information you provide to your veterinarian can significantly influence the diagnostic plan and treatment decisions. Before your veterinary visit, it is helpful to keep a detailed log of your pet's clinical signs. Note the date and time of each vomiting episode, the appearance of the vomitus (undigested food, bile, blood, or coffee-ground material), and any relationship to meals or medication administration. If your pet has diarrhea, record the frequency, consistency, and whether there is fresh blood or melena. Melena, which appears as black, tarry, sticky stools, indicates digested blood and suggests bleeding in the upper gastrointestinal tract. This is an important finding that should be reported to your veterinarian immediately. You should also document your pet's appetite and water intake. A decrease in appetite is common in pets with gastrointestinal disease, but the duration and severity matter. If your pet has not eaten for more than 24 hours, this is a concerning sign that warrants prompt veterinary attention. Weight loss is another important indicator. If you have been weighing your pet at home, bring those records to the visit. Changes in weight can help your veterinarian assess the chronicity and severity of the disease. Prepare a complete medication list, including any over-the-counter supplements, flea and tick preventives, and heartworm medications. Many pet owners do not consider supplements to be medications, but they can interact with prescribed drugs. For example, iron supplements can be irritating to the stomach, and some joint supplements contain ingredients that may affect gastric acid secretion. If your pet has been receiving any NSAID, such as carprofen, meloxicam, or aspirin, it is essential to disclose this. NSAID use is one of the most common causes of [gastric ulcers in dogs](/knowledge/veterinary-medicine/clinical-methods/canine-gastric-ulceration-diagnosis-management), and the timing of NSAID administration relative to the onset of signs is clinically relevant. When you speak with your veterinarian, be prepared to answer questions about your pet's environment and access to toxins. Dogs and cats can ingest a wide range of household items that cause vomiting, including chocolate, grapes, onions, xylitol-containing products, and certain houseplants. Rodenticides and other pesticides can also cause gastrointestinal signs. If there is any possibility of toxin exposure, this information is critical for guiding the diagnostic workup and treatment. Do not wait until the veterinary visit to mention potential exposures; call your veterinarian or a pet poison control hotline immediately if you suspect your pet has ingested something toxic. ## Prevention Strategies for Recurrent Acid-Related Disease Preventing recurrence of gastric ulcers and esophagitis requires a multifaceted approach that addresses the underlying risk factors. For pets on long-term NSAID therapy, the decision to use a gastroprotectant should be made based on the individual patient's risk profile. Older pets, those with a history of gastrointestinal disease, and those receiving high doses or multiple NSAIDs are at increased risk. The 2020 study by Satoh and colleagues in mice found that H2 receptor antagonists, including famotidine, did not prevent NSAID-induced antral ulcers, while PPIs were effective [11]. This finding suggests that for NSAID prophylaxis, PPIs may be the preferred choice. However, famotidine may still have a role in pets that cannot tolerate PPIs or that require rapid acid suppression. Dietary management is another component of prevention. While no specific diet has been proven to prevent ulcers in otherwise healthy pets, feeding a highly digestible, low-fat diet can reduce gastric irritation during episodes of gastritis. For pets with chronic gastrointestinal disease, your veterinarian may recommend a prescription gastrointestinal diet that is formulated to be gentle on the stomach and intestines. These diets often contain prebiotics and omega-3 fatty acids, which may support mucosal health. It is important to introduce any dietary change gradually over 7 to 10 days to avoid causing additional gastrointestinal upset. Stress reduction is an often-overlooked aspect of prevention. In hospitalized pets, stress can increase gastric acid secretion and contribute to the development of stress ulcers. Minimizing noise, providing comfortable bedding, and ensuring adequate analgesia are important nursing measures. At home, reducing environmental stressors, such as changes in routine, introduction of new pets, or loud noises, may help pets with stress-related gastrointestinal signs. However, it is important to recognize that stress is rarely the sole cause of gastric ulcers, and addressing stress does not replace the need for appropriate medical therapy. For pets with mast cell tumors, famotidine is used as part of a broader treatment plan. Mast cell tumors release histamine, which stimulates gastric acid secretion and can cause ulcers. The use of famotidine in these patients is prophylactic, aimed at preventing histamine-driven ulceration while the tumor is being treated. This is a situation where famotidine is clearly indicated, and the dose is typically at the higher end of the range. Your veterinary oncologist will coordinate the use of famotidine with other medications, such as antihistamines like diphenhydramine, to manage the effects of histamine release. ## Prognosis and Long-Term Monitoring The prognosis for pets with acid-related disease varies widely depending on the underlying cause and the timeliness of intervention. For pets with simple gastritis or mild esophagitis, the prognosis is excellent. Most pets respond to a short course of acid suppression, dietary modification, and supportive care within a few days. For pets with NSAID-induced ulcers, the prognosis is also generally good, provided the offending drug is discontinued and appropriate acid suppression is initiated. Most ulcers heal within 2 to 4 weeks with treatment, and repeat endoscopy is not always necessary unless there is concern about incomplete healing or malignancy. For pets with gastric neoplasia, the prognosis is more guarded. Gastric tumors, particularly adenocarcinoma and leiomyosarcoma, carry a poor prognosis, and surgery is often the primary treatment. Acid suppression with famotidine may be used to manage symptoms, but it does not treat the underlying tumor. For pets with inflammatory bowel disease, the prognosis is variable and depends on the response to immunosuppressive therapy and dietary management. Acid suppression is often used as an adjunctive treatment to reduce secondary esophagitis and gastritis. For critically ill pets with gastrointestinal bleeding, the prognosis depends on the severity of the bleeding and the underlying critical illness. The 2020 study by Kuhl and colleagues noted that upper GI ulceration and bleeding in critically ill dogs can cause severe anemia and increase morbidity [2]. These patients require intensive monitoring, including serial hematocrit measurements, blood pressure monitoring, and possibly blood transfusions. The goal of acid suppression in these patients is to prevent further bleeding and allow clots to stabilize. Famotidine CRI may be preferred in this setting because it provides more consistent acid suppression than intermittent dosing [1]. Long-term monitoring for pets on famotidine should include regular veterinary rechecks. The frequency of rechecks depends on the underlying condition and the duration of therapy. For pets on short-term therapy, a recheck may be scheduled 1 to 2 weeks after starting treatment to assess response. For pets on long-term therapy, rechecks every 3 to 6 months may be recommended. Blood work, including renal function tests, is particularly important for pets on long-term famotidine, especially older cats with CKD. Your veterinarian may also recommend monitoring for signs of gastrointestinal bleeding, such as checking fecal occult blood or measuring serial hematocrit. ## Special Population Considerations Certain populations of dogs and cats require special consideration when using famotidine. Pediatric patients, for example, have developing organ systems and may metabolize drugs differently than adults. There is limited published data on famotidine use in puppies and kittens, so dosing is often extrapolated from adult animals on a weight basis. However, the immaturity of the renal and hepatic systems in very young animals may necessitate dose adjustments. Your veterinarian will consider the age of your pet when selecting a dose and dosing interval. Geriatric patients are another special population. Older pets are more likely to have concurrent diseases, such as CKD, liver disease, or heart disease, which can affect drug handling. The dose of famotidine may need to be reduced or the dosing interval extended in geriatric pets with reduced renal function. Additionally, geriatric pets are more likely to be on multiple medications, increasing the risk of drug interactions. A thorough medication review is essential before starting famotidine in an older pet. Pregnant or nursing animals present a unique challenge. There is limited safety data on famotidine use in pregnant dogs and cats. In human medicine, famotidine is classified as a category B drug, meaning that animal reproduction studies have not demonstrated a risk to the fetus, but adequate human studies are lacking. In veterinary medicine, the decision to use famotidine in a pregnant animal must weigh the potential benefit against the unknown risk to the developing fetus. Famotidine is excreted in milk, so nursing animals may pass the drug to their offspring. Your veterinarian will discuss these considerations with you if your pet is pregnant or nursing. Pets with liver disease require careful monitoring when receiving famotidine. While famotidine is primarily eliminated through the kidneys, the liver plays a role in drug metabolism. Pets with severe liver disease may have altered drug clearance, and the dose may need to be adjusted. Additionally, pets with liver disease are at increased risk for gastrointestinal ulceration due to portal hypertension and coagulopathy, so acid suppression may be particularly important in these patients. However, the dose must be individualized to avoid drug accumulation. Pets with kidney disease, particularly cats with CKD, are a population where famotidine is commonly used. Uremic gastritis is a frequent complication of CKD, and acid suppression can improve appetite and reduce vomiting. However, because famotidine is eliminated through the kidneys, the dose must be adjusted in pets with reduced renal function. In cats with advanced CKD, the dosing interval may be extended to every 24 hours or the dose reduced. Your veterinarian will determine the appropriate dose based on your pet's kidney function tests, including serum creatinine and blood urea nitrogen levels. ## Practical Guidance for Administering Famotidine at Home Administering famotidine to your pet at home requires attention to detail to ensure the medication is effective and safe. The first step is to confirm the dose with your veterinarian and understand the tablet strength you have been given. Famotidine tablets are available in several strengths, including 10 mg, 20 mg, and 40 mg. For small dogs and cats, the 10 mg tablet may be appropriate, while larger dogs may require the 20 mg or 40 mg strength. It is essential to use the exact dose prescribed by your veterinarian and not to split tablets unless you have been instructed to do so. Splitting tablets can result in inaccurate dosing, as the medication may not be evenly distributed throughout the tablet. Famotidine can be given with or without food, but giving it on an empty stomach may improve absorption. If your pet is prone to nausea, giving famotidine with a small amount of food may help prevent vomiting. However, food can reduce the rate of absorption, so the peak effect may be delayed. For pets that are fasting for diagnostic procedures, famotidine can be given with a small amount of water. It is important to ensure that your pet swallows the medication and does not spit it out. If your pet refuses the tablet, you may need to hide it in a small amount of a highly palatable treat, such as peanut butter or cream cheese. However, be cautious with treats that are high in fat, as they can exacerbate gastrointestinal signs. If you miss a dose of famotidine, give the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not give a double dose to make up for a missed one, as this can increase the risk of side effects. If you are unsure whether to give a missed dose, contact your veterinarian for guidance. It is also important to store famotidine properly. The medication should be kept at room temperature, away from moisture and direct sunlight. Do not store famotidine in the bathroom, as the humidity can degrade the medication. Keep the medication out of reach of children and pets. If you have unused famotidine, do not save it for future use without consulting your veterinarian. The medication may expire, and the underlying condition may change, requiring a different treatment approach. ## Recognizing Adverse Effects and When to Seek Immediate Care While famotidine is generally well tolerated in dogs and cats, adverse effects can occur. The most common side effects are gastrointestinal, including diarrhea, vomiting, and reduced appetite. These side effects are usually mild and transient, but they can be concerning for pet owners. If your pet develops diarrhea or vomiting after starting famotidine, contact your veterinarian. In some cases, the side effects may resolve on their own, but in other cases, the dose may need to be adjusted or the medication discontinued. More serious adverse effects are rare but can occur. Allergic reactions, including facial swelling, hives, and difficulty breathing, require immediate veterinary attention. Neurologic signs, such as lethargy, depression, or seizures, have been reported in rare cases, particularly with high doses or in pets with renal impairment. If your pet shows any of these signs, stop the medication and seek emergency veterinary care immediately. It is also important to recognize signs of gastrointestinal bleeding, which may indicate that the underlying condition is worsening or that the famotidine is not providing adequate acid suppression. Signs of gastrointestinal bleeding include black, tarry stools (melena), vomiting blood (hematemesis), pale gums, weakness, and collapse. If your pet shows any of these signs, do not wait to see if they improve. Seek emergency veterinary care immediately. Gastrointestinal bleeding can be life-threatening, and prompt intervention is essential. Finally, it is important to remember that famotidine is not a cure for the underlying condition. It is a symptomatic treatment that reduces acid production, allowing the gastrointestinal tract to heal. If your pet does not show improvement within 48 hours of starting famotidine, or if the signs worsen at any time, contact your veterinarian. The underlying condition may require additional diagnostics or a different treatment approach. Your veterinarian is your partner in managing your pet's health, and open communication is essential for the best outcome. ## Veterinary Disclaimer This article is educational and is not a substitute for veterinary diagnosis or treatment. Always consult a licensed veterinarian before administering any medication to your pet. The information provided here is based on published research and clinical guidelines, but individual cases vary. Your veterinarian is best positioned to recommend the appropriate dose and treatment plan for your dog or cat. ## Frequently Asked Questions **1. What is the correct famotidine dose for a dog?** The standard oral dose for dogs is 0.5 to 1.1 mg/kg every 12 hours, but your veterinarian may adjust this based on your dog's specific condition and overall health. **2. What is the correct famotidine dose for a cat?** The typical dose for cats is 0.5 to 1.0 mg/kg every 12 to 24 hours, and cats with kidney disease may need a reduced dosing frequency. **3. How quickly does famotidine work in dogs and cats?** Oral famotidine reaches peak blood levels in 1 to 2 hours, but it may take 24 to 48 hours of regular dosing to achieve consistent acid suppression. **4. Can I give my dog human famotidine (Pepcid)?** Only under explicit veterinary direction, and you must confirm the tablet strength and inactive ingredients are safe for your pet. **5. Is famotidine safe for long-term use in pets?** Long-term use is generally considered safe, but it may affect the absorption of other medications and can theoretically impact nutrient status, so regular veterinary monitoring is recommended. **6. What is the difference between famotidine and omeprazole for pets?** Famotidine is an H2 blocker that provides faster but shorter-lasting acid suppression, while omeprazole is a proton pump inhibitor that is more potent and longer-acting, though it takes longer to reach full effect. **7. Can famotidine be given with food?** Famotidine can be given with or without food, but giving it on an empty stomach may improve absorption; follow your veterinarian's specific instructions. **8. What should I do if I miss a dose of famotidine for my pet?** Give the missed dose as soon as you remember, but skip it if it is almost time for the next dose; never give a double dose. ## Veterinary Disclaimer This article is educational and is not a substitute for veterinary diagnosis or treatment. Always consult a licensed veterinarian before administering any medication to your pet. The information provided here is based on published research and clinical guidelines, but individual cases vary. Your veterinarian is best positioned to recommend the appropriate dose and treatment plan for your dog or cat. ## Sources [1] [Evaluation of the effect of a famotidine continuous rate infusion on intragastric pH in healthy dogs.](https://pubmed.ncbi.nlm.nih.gov/31294879/) [2] [Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs.](https://pubmed.ncbi.nlm.nih.gov/32020689/) [3] [Effect of felodipine on indomethacin-induced gastric ulcers in rats.](https://pubmed.ncbi.nlm.nih.gov/37316263/) [4] [Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.](https://pubmed.ncbi.nlm.nih.gov/33230059/) [5] [Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects.](https://pubmed.ncbi.nlm.nih.gov/37382329/) [6] [Pharmacodynamics Between a Dual Delayed-Release Formulation of Low-Dose Esomeprazole and Famotidine in Healthy Korean Subjects.](https://pubmed.ncbi.nlm.nih.gov/39033046/) [7] [Prodrug Strategy to Address Impaired Oral Absorption of a Weakly Basic TYK2 Inhibitor Caused by a Gastric Acid-Reducing Agent.](https://pubmed.ncbi.nlm.nih.gov/39560351/) [8] [Effect of gastric pH and of a moderate CYP3A4 inducer on the pharmacokinetics of daridorexant, a dual orexin receptor antagonist.](https://pubmed.ncbi.nlm.nih.gov/34371524/) [9] [Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist.](https://pubmed.ncbi.nlm.nih.gov/38346861/) [10] [Impact of famotidine on blood carnitine levels and L-carnitine supplementation dose in tube-fed patients with severe motor and intellectual disabilities.](https://pubmed.ncbi.nlm.nih.gov/41145993/) [11] [Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs via Activation of Capsaicin-Sensitive Afferent Nerves in Mice.](https://pubmed.ncbi.nlm.nih.gov/32140944/) [12] [Role of Famotidine and Other Acid Reflux Medications for SARS-CoV-2: A Pilot Study.](https://pubmed.ncbi.nlm.nih.gov/33516648/) [13] [Masking the Taste of Fixed-Dose Combination Drugs: Particular NSAIDs Can Efficiently Mask the Bitterness of Famotidine.](https://pubmed.ncbi.nlm.nih.gov/36724977/) [14] [The Effect of Gastric pH on the Pharmacokinetics-pharmacodynamics of Naphthoquine in Rodents, as well as in Human Predicted Using a PBPK Model.](https://pubmed.ncbi.nlm.nih.gov/33511926/) [15] [Radioprotective Effects of Vitamin C, Cimetidine, and Famotidine on Lipid Peroxidase and Hepatic Glutathione Levels in Mouse Liver.](https://pubmed.ncbi.nlm.nih.gov/39803629/) [16] [Investigation of the effects of rainbow trout (Oncorhynchus mykiss) skin mucus against indomethacin-induced gastric damage in rats.](https://pubmed.ncbi.nlm.nih.gov/39673571/) [17] [Effects of taxifolin on aspirin-induced gastric damage in rats: macroscopic and biochemical evaluation.](https://pubmed.ncbi.nlm.nih.gov/37331803/) [18] [Apple (Malus domestica Borkh) leaves attenuate indomethacin-induced gastric ulcer in rats.](https://pubmed.ncbi.nlm.nih.gov/36736281/) [19] [Combined effect of oral famotidine and cimetidine on the survival of lethally irradiated mice: An in vivo study.](https://pubmed.ncbi.nlm.nih.gov/34528533/) [20] [The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects.](https://pubmed.ncbi.nlm.nih.gov/30768860/) ## Related Clinical & Scientific Guides * [Drontal Plus Dewormer: Broad-Spectrum Dose Guide by Weight](/knowledge/veterinary-medicine/calculators-clinical-tools/drontal-plus-dewormer-broad-spectrum-dose-guide-by-weight) * [Panacur Fenbendazole Dewormer: Dog Fecal Parasite Treatment Schedule](/knowledge/veterinary-medicine/calculators-clinical-tools/panacur-fenbendazole-dewormer-dog-fecal-parasite-treatment-schedule) * [Prednisolone for Cats: Feline Safe Steroid Dose and Autoimmune](/knowledge/veterinary-medicine/calculators-clinical-tools/prednisolone-for-cats-feline-safe-steroid-dose-and-autoimmune)